A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer
被引:240
作者:
Eeckhoute, Jerome
论文数: 0引用数: 0
h-index: 0
机构:Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA
Eeckhoute, Jerome
Carroll, Jason S.
论文数: 0引用数: 0
h-index: 0
机构:Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA
Carroll, Jason S.
Geistlinger, Timothy R.
论文数: 0引用数: 0
h-index: 0
机构:Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA
Geistlinger, Timothy R.
Torres-Arzayus, Maria I.
论文数: 0引用数: 0
h-index: 0
机构:Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA
Torres-Arzayus, Maria I.
Brown, Myles
论文数: 0引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USADana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA
Brown, Myles
[1
]
机构:
[1] Dana Farber Canc Inst, Dept Med Oncol, Div Mol & Cellular Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
breast cancer;
estrogen receptor;
cyclin D1;
transcription;
enhancer;
chromatin;
D O I:
10.1101/gad.1446006
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Estrogen stimulates the proliferation of the most common type of human breast cancer that expresses estrogen receptor alpha(ER alpha) through the activation of the cyclin D1 (CCND1) oncogene. However, our knowledge of ER alpha transcriptional mechanisms remains limited. Hence, it is still elusive why ER alpha ectopically expressed in ER-negative breast cancer cells (BCC) is functional on ectopic reporter constructs but lacks activity on many endogenous target genes, including CCND1. Here, we show that estradiol (E2) stimulation of CCND1 expression in BCC depends on a novel cell-type-specific enhancer downstream from the CCND1 coding region, which is the primary ER alpha recruitment site in estrogen-responsive cells. The pioneer factor FoxA1 is specifically required for the active chromatin state of this enhancer and as such is crucial for both CCND1 expression and subsequent cell cycle progression. Interestingly, even in BCC, CCND1 levels and proliferation are tightly controlled by E2 through the establishment of a negative feedforward loop involving the induction of NFIC, a putative tumor suppressor capable of directly repressing CCND1 transcription. Taken together, our results reveal an estrogen-regulated combinatorial network including cell-specific cis- and trans-regulators of CCND1 expression where ER alpha collaborates with other transcription factors associated with the ER-positive breast cancer phenotype, including FoxA1 and NFIC.